作者
Soji Nishio, Kunihiko Kosuga, Keiji Igaki, Masaharu Okada, Eisho Kyo, Takafumi Tsuji, Eiji Takeuchi, Yasutaka Inuzuka, Shinsaku Takeda, Tatsuhiko Hata, Yuzo Takeuchi, Yoshitaka Kawada, Takeshi Harita, Junya Seki, Shunji Akamatsu, Shinichi Hasegawa, Nico Bruining, Salvatore Brugaletta, Sebastiaan De Winter, Takashi Muramatsu, Yoshinobu Onuma, Patrick W Serruys, Shigeru Ikeguchi
发表日期
2012/5/15
期刊
Circulation
卷号
125
期号
19
页码范围
2343-2353
出版商
Lippincott Williams & Wilkins
简介
Background
The purpose of this study was to evaluate the long-term safety of the Igaki-Tamai stent, the first-in-human fully biodegradable coronary stent made of poly-l-lactic acid.
Methods and Results
Between September 1998 and April 2000, 50 patients with 63 lesions were treated electively with 84 Igaki-Tamai stents. Overall clinical follow-up (>10 years) of major adverse cardiac events and rates of scaffold thrombosis was analyzed together with the results of angiography and intravascular ultrasound. Major adverse cardiac events included all-cause death, nonfatal myocardial infarction, and target lesion revascularization/target vessel revascularization. During the overall clinical follow-up period (121±17 months), 2 patients were lost to follow-up. There were 1 cardiac death, 6 noncardiac deaths, and 4 myocardial infarctions. Survival rates free of all-cause death, cardiac death, and major adverse cardiac events at …
学术搜索中的文章
S Nishio, K Kosuga, K Igaki, M Okada, E Kyo, T Tsuji… - Circulation, 2012
